- Generic name
- Esomeprazole
- Strength
- 40 mg
- Dosage form
- Tablet
- Manufactured by
- Amico Laboratories Ltd.
Prazia 40 Tablet
About Prazia 40 Tablet
Prazia 40 is a tablet from Amico Laboratories Ltd., with the generic name Esomeprazole. Only a doctor can confirm whether your symptoms fit these uses and whether this medicine is right for you.
There are 161 brands of Esomeprazole listed in Bangladesh. The lowest listed price is Emo 20 mg Tablet at ৳ 1 per unit.
What is Prazia 40 Tablet?
Prazia 40 40 mg tablet is a medicine made by Amico Laboratories Ltd. Prazia 40 40 mg tablet contains Esomeprazole, a proton pump inhibitor that lowers stomach acid. It works by blocking the acid-producing mechanism in the stomach, so less acid is released. Your doctor will decide how long you need it.
Uses of Prazia 40
Only a doctor can confirm whether your symptoms fit these uses and whether this medicine is right for you. Only a doctor can decide if this medicine is appropriate for a particular patient. Pylori infection in people with duodenal ulcer disease. Your doctor will confirm whether this medicine is suitable for your condition.
How to use Prazia 40
The tablet can be swallowed whole or dispersed in water if you have trouble swallowing. Swallow the tablet with water. Prazia 40 is taken by mouth. Take Prazia 40 exactly as prescribed by your doctor. The doctor decides the dose and how long you take it, so follow their instructions rather than any general advice. Complete the course exactly as prescribed.
Side effects of Prazia 40
Serious side effects are rare, but seek medical help immediately if you notice signs of an allergic reaction such as rash, swelling, or difficulty breathing, or any other severe symptom. The types of side effects seen during longer maintenance treatment were similar to those seen with short-term use. The most common ones include headache, diarrhoea, nausea, wind (flatulence), stomach pain, constipation, and dry mouth. Tell your doctor or nurse if you feel unwell or notice any unusual symptom after a dose, so they can advise you. Your doctor will assess whether the medicine needs to be continued or adjusted.
Safety and precautions
There are no adequate studies in pregnant women; animal studies showed no teratogenic effects. Do not take Prazia 40 40 mg tablet if you are allergic to Esomeprazole or any ingredient in it. Esomeprazole in breast milk has not been studied, and breastfeeding should be discontinued if its use is considered essential. Tell your doctor about all the other medicines you take.
Frequently asked questions
Why is Prazia 40 prescribed?
Only a doctor can confirm whether your symptoms fit these uses and whether this medicine is right for you. Only a doctor can decide if this medicine is appropriate for a particular patient.
How do I use Prazia 40 correctly?
The tablet can be swallowed whole or dispersed in water if you have trouble swallowing. Swallow the tablet with water.
Can Prazia 40 cause side effects?
Serious side effects are rare, but seek medical help immediately if you notice signs of an allergic reaction such as rash, swelling, or difficulty breathing, or any other severe symptom. The types of side effects seen during longer maintenance treatment were similar to those seen with short-term use.
Who should be careful with Prazia 40?
There are no adequate studies in pregnant women; animal studies showed no teratogenic effects. Do not take Prazia 40 40 mg tablet if you are allergic to Esomeprazole or any ingredient in it.
Also available as
Indications
- To relieve from chronic heartburn symptoms and other symptoms associated with GERD
- For the healing of erosive esophagitis
- For maintenance of healing of erosive esophagitis
- In combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori infection in patients with duodenal ulcer disease. ... Read more
- To relieve from chronic heartburn symptoms and other symptoms associated with GERD
- For the healing of erosive esophagitis
- For maintenance of healing of erosive esophagitis
- In combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori infection in patients with duodenal ulcer disease.
- Zollinger-Ellison Syndrome
- Acid related Dyspepsia
- Duodenal & Gastric ulcer
Pharmacology
Absorption: Esomeprazole capsules contain an enteric-coated pellet formulation of esomeprazole magnesium. After oral administration peak plasma levels (Cmax) occur at approximately 1.5 hours (Tmax). The Cmax increases proportionally when the dose is increased, and there is a three-fold increase in the area under the plasma concentration-time curve (AUC) from 20 to 40 mg. At repeated once daily dosing, the systemic bioavailability is approximately 90% compared to 64% after a single dose. The AUC after administration of a single dose of esomeprazole is decreased by 33-53% after food intake compared to fasting conditions. Esomeprazole should be taken at least one hour before meals.
Distribution: Esomeprazole is 97% bound to plasma proteins. Plasma protein binding is constant over the concentration range of 2 20 mmol/L. The apparent volume of distribution at steady state in healthy volunteers is approximately 16 L.
Metabolism: Esomeprazole is extensively metabolized in the liver by the cytochrome P450 (CYP) enzyme system. The metabolites of esomeprazole lack anti-secretory activity. The major part of esomeprazole’s metabolism is dependent upon the CYP2C19 isoenzyme, which forms the hydroxy and desmethyl metabolites. The remaining amount is dependent on CYP3A4 which forms the sulphone metabolite.
Excretion: The plasma elimination half-life of esomeprazole is approximately 1–1.5 hours. Less than 1% of parent drug is excreted in the urine. Approximately 80% of an oral dose of esomeprazole is excreted as inactive metabolites in the urine, and the remainder is found as inactive metabolites in the faeces.
Combination Therapy with Antimicrobials: Esomeprazole magnesium 40 mg once daily is given in combination with clarithromycin 500 mg twice daily and amoxicillin 1000 mg twice daily for 7 days. The mean steady state AUC and Cmax of Esomeprazole increased by 70% and 18%, respectively, during triple combination therapy compared to treatment with Esomeprazole alone. The pharmacokinetic parameters for clarithromycin and amoxicillin are similar during triple combination therapy and administration of each drug alone. However, the mean AUC and Cmax for 14-hydroxyclarithromycin are increased by 19% and 22%, respectively, during triple combination therapy compared to treatment with clarithromycin alone. This increase in exposure to 14-hydroxyclarithromycin is not considered to be clinically significant.
Dosage & Administration
Healing of Erosive Esophagitis: 20 mg or 40 mg Once Daily for 4-8 Weeks. The majority of patients are healed within 4 to 8 weeks. For patients who don't heal after 4-8 weeks, an additional 4-8 weeks of treatment may be considered. Maintenance of Healing of Erosive
Esophagitis: 20 mg Once Daily (Clinical studies did not extend 6 months).
Symptomatic GERD: 20 mg Once Daily for 4 Weeks. If symptoms do not resolve completely after 4 weeks, an additional 4 weeks of treatment may be considered.
Helicobacter Pylori eradication: Triple Therapy to reduce the risk of Duodenal Ulcer recurrence-Esomeprazole 40 mg Once Daily for 10 days, Amoxicillin 1000 mg Twice Daily for 10 days, Clarithromycin 500 mg Twice Daily for 10 days.
Zollinger-Ellison Syndrome: The dose is 20-80 mg once daily. The dosage should be adjusted individually and treatment continued as long as clinically indicated.
Acid-related Dyspepsia: 20-40 mg once daily for 2-4 weeks according to the response.
Duodenal ulcer: 20 mg once daily for 2-4 weeks. Gastric ulcer: 20-40 mg once daily for 4-8 weeks.
Injection: The recommended adult dose is 40 mg Esomeprazole given once daily by intravenous injection (not less than 3 minutes) or intravenous infusion (10 to 30 minutes). Esomeprazole IV injection should not be administered concomitantly with any other medications through the same intravenous site. Treatment with Esomeprazole IV injection should be discontinued as soon as the patient is able to resume treatment with Esomeprazole delayed-release capsules. Safety and effectiveness in paediatric patients have not been established.
Interaction
Esomeprazole may potentially interfere with CYP2C19, the major Esomeprazole metabolizing enzyme. Co-administration of Esomeprazole 30 mg and diazepam, a CYP2C19 substrate has resulted in a 45% decrease in clearance of diazepam. Increased plasma levels of diazepam have been observed 12 hours after dosing and onwards. Esomeprazole inhibits gastric acid secretion. Therefore, Esomeprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (e.g., ketoconazole, iron salts and digoxin).
Co-administration of oral contraceptives, diazepam, phenytoin, or quinidine do not seem to change the pharmacokinetic profile of Esomeprazole.
Combination Therapy with Clarithromycin: Co-administration of esomeprazole, clarithromycin, and amoxicillin has resulted in increases in the plasma levels of esomeprazole and 14-hydroxyclarithromycin.
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Information for patients: Esomeprazole capsules should be taken at least one hour before meals. For patients who have difficulty swallowing capsules, one tablespoon of applesauce can be added to an empty bowl and the Esomeprazole capsules can be opened, and the pellets inside the capsule carefully emptied onto the applesauce. The pellets should be mixed with the applesauce and then swallowed immediately. The applesauce used should not be hot and should be soft enough to be swallowed without chewing. The pellets should not be chewed or crushed. The pellet/applesauce mixture should not be stored for future use. Antacids may be used while taking esomeprazole.
Overdose Effects
Storage Conditions
Alternative brands of Esomeprazole
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.